PriceTargets.com logo

Medtronic - MDT Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $95.19
  • Forecasted Upside: 13.17%
  • Number of Analysts: 18
  • Breakdown:
  • 1 Sell Ratings
  • 9 Hold Ratings
  • 7 Buy Ratings
  • 1 Strong Buy Ratings
$84.11 As of 11/20/2024 01:00 AM ET
▼ -0.89 (-1.05%)

This chart shows the closing price for MDT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Medtronic Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MDT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MDT

Analyst Price Target is $95.19
▲ +13.17% Upside Potential
This price target is based on 18 analysts offering 12 month price targets for Medtronic in the last 3 months. The average price target is $95.19, with a high forecast of $105.00 and a low forecast of $83.00. The average price target represents a 13.17% upside from the last price of $84.11.

This chart shows the closing price for MDT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 18 contributing investment analysts is to hold stock in Medtronic. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 8 hold ratings
  • 2 sell ratings
Ratings as of
5/30/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
11/26/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
2/24/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
5/24/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 9 hold ratings
  • 1 sell ratings
Ratings as of
8/22/2024
  • 1 strong buy ratings
  • 6 buy ratings
  • 8 hold ratings
  • 1 sell ratings
Ratings as of
10/21/2024
  • 1 strong buy ratings
  • 7 buy ratings
  • 9 hold ratings
  • 1 sell ratings
Ratings as of
11/20/2024

Latest Recommendations

  • 1 strong buy ratings
  • 7 buy ratings
  • 9 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/20/2024Sanford C. BernsteinBoost TargetOutperform ➝ Outperform$96.00 ➝ $97.00
11/20/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$106.00 ➝ $98.00
11/20/2024Robert W. BairdLower TargetNeutral ➝ Neutral$96.00 ➝ $93.00
11/18/2024Needham & Company LLCReiterated RatingHold
11/15/2024Robert W. BairdBoost Target$90.00 ➝ $96.00
11/15/2024JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$99.00 ➝ $96.00
10/25/2024Needham & Company LLCReiterated RatingHold
10/14/2024Truist FinancialBoost TargetHold ➝ Hold$90.00 ➝ $93.00
10/10/2024Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$98.00 ➝ $105.00
10/8/2024Royal Bank of CanadaBoost TargetSector Perform ➝ Sector Perform$92.00 ➝ $98.00
10/1/2024CitigroupBoost TargetNeutral ➝ Neutral$85.00 ➝ $92.00
10/1/2024Evercore ISIBoost TargetOutperform ➝ Outperform$100.00 ➝ $104.00
8/23/2024Daiwa AmericaUpgradeStrong-Buy
8/23/2024Truist FinancialBoost TargetHold ➝ Hold$85.00 ➝ $90.00
8/22/2024BarclaysBoost TargetOverweight ➝ Overweight$104.00 ➝ $105.00
8/21/2024Piper SandlerBoost TargetNeutral ➝ Neutral$85.00 ➝ $90.00
8/21/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$105.00 ➝ $106.00
8/21/2024Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$92.00 ➝ $92.00
8/21/2024Stifel NicolausBoost TargetHold ➝ Hold$85.00 ➝ $87.00
8/21/2024Robert W. BairdBoost TargetNeutral ➝ Neutral$82.00 ➝ $90.00
8/21/2024OppenheimerBoost TargetMarket Perform ➝ Market Perform$92.00 ➝ $94.00
8/20/2024Needham & Company LLCReiterated RatingHold
8/15/2024UBS GroupUpgradeSell ➝ Neutral$76.00 ➝ $90.00
8/14/2024Stifel NicolausDowngradeBuy ➝ Hold$100.00 ➝ $85.00
8/12/2024Needham & Company LLCReiterated RatingHold
7/17/2024Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$92.00 ➝ $92.00
7/16/2024Truist FinancialLower TargetHold ➝ Hold$88.00 ➝ $85.00
7/10/2024CitigroupLower TargetNeutral ➝ Neutral$90.00 ➝ $85.00
6/5/2024Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$92.00 ➝ $92.00
5/30/2024The Goldman Sachs GroupInitiated CoverageSell$83.00
5/24/2024Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$92.00
5/24/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$102.00 ➝ $105.00
5/24/2024UBS GroupBoost TargetSell ➝ Sell$75.00 ➝ $76.00
5/24/2024Truist FinancialLower TargetHold ➝ Hold$90.00 ➝ $88.00
5/24/2024Needham & Company LLCReiterated RatingHold
2/21/2024Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$92.00
2/21/2024MizuhoBoost TargetBuy ➝ Buy$95.00 ➝ $98.00
2/21/2024OppenheimerBoost TargetMarket Perform ➝ Market Perform$89.00 ➝ $92.00
2/21/2024Truist FinancialBoost TargetHold ➝ Hold$87.00 ➝ $90.00
1/12/2024Royal Bank of CanadaBoost TargetSector Perform ➝ Sector Perform$82.00 ➝ $92.00
12/22/2023Truist FinancialBoost TargetHold ➝ Hold$84.00 ➝ $87.00
11/22/2023Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$82.00
11/22/2023Morgan StanleyLower TargetOverweight ➝ Overweight$104.00 ➝ $98.00
8/23/2023OppenheimerReiterated RatingMarket Perform ➝ Market Perform$89.00
8/23/2023Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$89.00
8/23/2023UBS GroupBoost TargetSell ➝ Sell$79.00 ➝ $82.00
8/23/2023MizuhoBoost TargetBuy ➝ Buy$95.00 ➝ $100.00
8/23/2023Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$100.00 ➝ $102.00
8/22/2023Stifel NicolausBoost TargetBuy ➝ Buy$92.00 ➝ $95.00
7/18/2023Robert W. BairdInitiated CoverageNeutral$90.00
6/30/202322nd Century GroupReiterated RatingInitiates
6/30/2023CL KingInitiated CoverageBuy$106.00
5/30/2023Morgan StanleyUpgradeEqual Weight ➝ Overweight$104.00
5/26/2023Truist FinancialLower Target$93.00 ➝ $90.00
5/26/2023Stifel NicolausBoost Target$90.00 ➝ $92.00
5/26/2023Sanford C. BernsteinLower Target$100.00 ➝ $99.00
4/24/2023Truist FinancialBoost Target$88.00 ➝ $93.00
4/24/2023BarclaysUpgradeEqual Weight ➝ Overweight
4/24/2023Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$77.00 ➝ $100.00
4/21/2023Royal Bank of CanadaReiterated RatingSector Perform$89.00
4/17/2023Truist FinancialLower TargetHold$90.00 ➝ $88.00
3/29/2023UBS GroupDowngradeBuy ➝ Sell$127.00 ➝ $79.00
2/22/2023Deutsche Bank AktiengesellschaftBoost Target$80.00 ➝ $87.00
1/24/2023MizuhoLower TargetBuy$100.00 ➝ $95.00
1/9/2023Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$102.00 ➝ $89.00
11/30/2022Wells Fargo & CompanyLower TargetEqual Weight$82.00 ➝ $77.00
11/25/2022BarclaysLower TargetEqual Weight$90.00 ➝ $85.00
11/23/2022CowenLower Target$117.00 ➝ $90.00
11/23/2022Royal Bank of CanadaLower TargetOutperform$110.00 ➝ $102.00
11/23/2022Morgan StanleyLower TargetEqual Weight$97.00 ➝ $88.00
11/23/2022Deutsche Bank AktiengesellschaftLower Target$85.00 ➝ $80.00
11/23/2022Truist FinancialLower Target$89.00 ➝ $84.00
11/23/2022CowenLower Target$117.00 ➝ $90.00
11/23/2022Stifel NicolausLower Target$105.00 ➝ $90.00
11/23/2022OppenheimerDowngradeOutperform ➝ Market Perform$106.00 ➝ $85.00
11/23/2022Wells Fargo & CompanyLower Target$96.00 ➝ $82.00
11/23/2022CitigroupDowngradeBuy ➝ Neutral$108.00 ➝ $85.00
11/22/2022Piper SandlerLower Target$90.00 ➝ $80.00
11/16/2022Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$85.00
10/17/2022BarclaysInitiated CoverageEqual Weight$90.00
10/17/2022Truist FinancialLower TargetHold$97.00 ➝ $89.00
10/12/2022MizuhoInitiated CoverageBuy$100.00
10/12/2022Jefferies Financial GroupInitiated CoverageHold$87.00
10/11/2022Morgan StanleyLower TargetEqual Weight$101.00 ➝ $97.00
10/5/2022CitigroupLower Target$110.00 ➝ $108.00
9/7/2022Royal Bank of CanadaLower Target$122.00 ➝ $110.00
8/24/2022Morgan StanleyLower TargetEqual Weight$103.00 ➝ $101.00
8/24/2022Wells Fargo & CompanyLower TargetEqual Weight$104.00 ➝ $96.00
8/24/2022Raymond JamesDowngradeOutperform ➝ Market Perform
8/23/2022Piper SandlerLower Target$100.00 ➝ $90.00
7/20/2022Truist FinancialLower TargetHold$111.00 ➝ $97.00
7/18/2022Stifel NicolausLower Target$125.00 ➝ $105.00
7/15/2022Morgan StanleyLower TargetEqual Weight$114.00 ➝ $103.00
7/5/2022Wolfe ResearchInitiated CoverageUnderperform$85.00
6/7/2022Morgan StanleyLower TargetEqual Weight$115.00 ➝ $114.00
6/1/2022Atlantic SecuritiesDowngradeOverweight ➝ Neutral$125.00 ➝ $105.00
5/31/2022Raymond JamesLower Target$116.00 ➝ $109.00
5/27/2022Truist FinancialLower TargetHold$121.00 ➝ $111.00
5/27/2022Morgan StanleyLower TargetEqual Weight$120.00 ➝ $115.00
5/27/2022Royal Bank of CanadaLower Target$135.00 ➝ $122.00
5/27/2022Deutsche Bank AktiengesellschaftLower Target$149.00 ➝ $121.00
5/27/2022CitigroupLower TargetBuy$120.00 ➝ $117.00
5/27/2022Needham & Company LLCDowngradeBuy ➝ Hold
5/26/2022Piper SandlerLower TargetNeutral$105.00 ➝ $100.00
5/23/2022CowenSet TargetOutperform$141.00 ➝ $125.00
5/23/2022CowenBoost Target$125.00
5/20/2022Sanford C. BernsteinReiterated RatingBuy$122.00
5/17/2022CitigroupLower Target$127.00 ➝ $120.00
4/13/2022Leerink PartnersReiterated RatingMarket Perform
4/13/2022Truist FinancialDowngradeBuy ➝ Hold$124.00 ➝ $121.00
3/1/2022Bank of AmericaInitiated CoverageBuy ➝ Buy
2/23/2022Credit Suisse GroupLower TargetOutperform$142.00 ➝ $135.00
2/23/2022Needham & Company LLCLower TargetBuy$128.00 ➝ $124.00
2/18/2022Raymond JamesLower TargetOutperform$127.00 ➝ $116.00
2/16/2022Piper SandlerLower TargetNeutral$110.00 ➝ $105.00
1/25/2022Needham & Company LLCLower TargetBuy$131.00 ➝ $128.00
1/21/2022Leerink PartnersLower TargetMarket Perform$138.00 ➝ $115.00
1/19/2022CitigroupLower TargetBuy$130.00 ➝ $129.00
1/18/2022The Goldman Sachs GroupLower TargetNeutral$129.00 ➝ $115.00
1/10/2022BTIG ResearchDowngradeBuy ➝ Neutral$104.00
1/7/2022Morgan StanleyDowngradeOverweight ➝ Equal Weight$145.00 ➝ $120.00
1/4/2022Piper SandlerDowngradeOverweight ➝ Neutral$152.00 ➝ $110.00
12/21/2021Truist FinancialLower TargetBuy$142.00 ➝ $124.00
12/20/2021Credit Suisse GroupLower TargetOutperform$146.00 ➝ $142.00
12/17/2021OppenheimerLower TargetOutperform$145.00 ➝ $136.00
12/17/2021BTIG ResearchLower TargetBuy$138.00 ➝ $128.00
12/17/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$130.00 ➝ $105.00
12/16/2021Needham & Company LLCLower TargetBuy$145.00 ➝ $131.00
12/16/2021Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$137.00 ➝ $110.00
12/9/2021Royal Bank of CanadaInitiated CoverageOutperform$140.00
11/24/2021Truist FinancialLower TargetBuy$148.00 ➝ $142.00
11/24/2021Morgan StanleyLower TargetOverweight$154.00 ➝ $145.00
11/24/2021Wells Fargo & CompanyLower TargetOverweight$144.00 ➝ $137.00
11/24/2021OppenheimerLower TargetOutperform$150.00 ➝ $145.00
11/24/2021CitigroupLower TargetBuy$153.00 ➝ $146.00
11/23/2021Needham & Company LLCLower TargetBuy$152.00 ➝ $145.00
10/18/2021Wells Fargo & CompanyLower TargetPositive ➝ Overweight$151.00 ➝ $144.00
8/27/2021ArgusBoost TargetPositive ➝ Buy$150.00 ➝ $165.00
8/25/2021Truist FinancialBoost TargetBuy$138.00 ➝ $148.00
8/25/2021Credit Suisse GroupBoost TargetOutperform$137.00 ➝ $146.00
8/25/2021Wells Fargo & CompanyBoost TargetOverweight$140.00 ➝ $151.00
8/25/2021Raymond JamesBoost TargetOutperform$135.00 ➝ $142.00
8/25/2021Stifel NicolausBoost TargetBuy$140.00 ➝ $145.00
8/25/2021UBS GroupBoost TargetBuy$145.00 ➝ $149.00
8/25/2021Morgan StanleyBoost TargetPositive ➝ Overweight$140.00 ➝ $154.00
8/25/2021CitigroupReiterated RatingFocus List$143.00 ➝ $153.00
8/24/2021Piper SandlerReiterated RatingOverweight$140.00 ➝ $152.00
8/9/2021BTIG ResearchDowngradeBuy ➝ Neutral
6/3/2021ArgusBoost TargetBuy$135.00 ➝ $150.00
5/28/2021Leerink PartnersBoost TargetMarket Perform$129.00 ➝ $138.00
5/28/2021Raymond JamesBoost TargetOutperform$128.00 ➝ $135.00
5/28/2021OppenheimerBoost TargetOutperform$134.00 ➝ $147.00
5/28/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$134.00 ➝ $149.00
5/28/2021CitigroupReiterated RatingBuy$133.00 ➝ $143.00
5/27/2021William BlairReiterated RatingMarket Perform
5/27/2021Piper SandlerBoost TargetPositive ➝ Overweight$130.00 ➝ $140.00
5/24/2021BarclaysInitiated CoverageEqual Weight$145.00
4/15/2021Atlantic SecuritiesInitiated CoverageOverweight$153.00
3/2/2021Leerink PartnersBoost TargetMarket Perform$123.00 ➝ $129.00
2/25/2021Raymond JamesBoost TargetOutperform$122.00 ➝ $128.00
2/25/2021Credit Suisse GroupBoost TargetOutperform$126.00 ➝ $130.00
2/24/2021CowenBoost TargetOutperform$120.00 ➝ $135.00
2/24/2021Leerink PartnersReiterated RatingMarket Perform$123.00 ➝ $129.00
2/24/2021Stifel NicolausBoost TargetBuy$132.00 ➝ $135.00
12/15/2020The Goldman Sachs GroupUpgradeSell ➝ Neutral$100.00 ➝ $119.00
12/15/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$140.00
11/25/2020Truist FinancialBoost TargetMarket Perform ➝ Buy$128.00
11/25/2020Smith Barney CitigroupBoost Target$120.00 ➝ $128.00
11/25/2020UBS GroupBoost TargetBuy$123.00 ➝ $130.00
11/25/2020Credit Suisse GroupBoost TargetPositive ➝ Outperform$118.00 ➝ $126.00
11/25/2020OppenheimerBoost TargetOutperform$122.00 ➝ $128.00
11/25/2020Raymond JamesBoost TargetOutperform$115.00 ➝ $122.00
11/25/2020Morgan StanleyBoost TargetEqual Weight$111.00 ➝ $120.00
11/25/2020Stifel NicolausBoost TargetPositive ➝ Buy$125.00 ➝ $132.00
11/25/2020BTIG ResearchBoost TargetBuy$119.00 ➝ $124.00
11/25/2020Leerink PartnersBoost TargetMarket Perform$110.00 ➝ $123.00
11/24/2020Piper SandlerBoost TargetOverweight$120.00 ➝ $130.00
11/18/2020Wells Fargo & CompanyBoost TargetPositive ➝ Overweight$118.00 ➝ $127.00
10/15/2020Jefferies Financial GroupBoost TargetBuy$120.00 ➝ $138.00
10/8/2020Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform
10/8/2020Stifel NicolausUpgradeHold ➝ Buy$125.00
9/11/2020Wolfe ResearchInitiated CoveragePeer Perform$115.00
8/26/2020BTIG ResearchBoost TargetBuy$102.00 ➝ $111.00
8/26/2020Leerink PartnersBoost TargetMarket Perform$105.00 ➝ $110.00
8/26/2020Morgan StanleyBoost TargetEqual Weight$106.00 ➝ $111.00
8/26/2020Credit Suisse GroupBoost TargetOutperform$117.00 ➝ $118.00
8/26/2020Raymond JamesBoost TargetOutperform$107.00 ➝ $115.00
8/26/2020CitigroupBoost TargetBuy$108.00 ➝ $120.00
8/25/2020OppenheimerReiterated RatingBuy$112.00
8/25/2020Needham & Company LLCBoost TargetBuy$113.00 ➝ $124.00
8/18/2020CowenReiterated RatingBuy$110.00
8/11/2020Piper SandlerReiterated RatingBuy$120.00
7/15/2020Needham & Company LLCReiterated RatingBuy$113.00
7/2/2020Credit Suisse GroupReiterated RatingBuy$117.00
5/27/2020SunTrust BanksLower Target$130.00 ➝ $105.00
5/23/2020CSFBReiterated RatingBuy$117.00
5/22/2020Credit Suisse GroupReiterated RatingBuy$117.00
5/22/2020Bank of AmericaReiterated RatingBuy$130.00
5/22/2020Jefferies Financial GroupBoost TargetBuy$110.00 ➝ $120.00
5/22/2020OppenheimerLower TargetOutperform$131.00 ➝ $112.00
5/22/2020UBS GroupLower TargetBuy$130.00 ➝ $118.00
5/22/2020Morgan StanleyLower TargetEqual Weight$112.00 ➝ $106.00
5/22/2020Raymond JamesLower TargetOutperform$110.00 ➝ $107.00
5/22/2020Deutsche Bank AktiengesellschaftLower TargetBuy$123.00 ➝ $118.00
5/21/2020OppenheimerInitiated CoverageBuy$131.00
5/21/2020Needham & Company LLCReiterated RatingBuy$113.00
5/21/2020Piper SandlerLower TargetOverweight$135.00 ➝ $120.00
5/21/2020CfraUpgradeBuy ➝ Strong-Buy$127.00 ➝ $121.00
5/14/2020DZ BankDowngradeBuy ➝ Hold$92.00
4/28/2020Leerink PartnersBoost TargetMarket Perform$100.00 ➝ $105.00
4/23/2020Sanford C. BernsteinReiterated RatingHold$112.00
4/22/2020Needham & Company LLCReiterated RatingBuy$109.00
4/22/2020Wells Fargo & CompanyLower TargetOverweight$130.00 ➝ $108.00
4/9/2020JPMorgan Chase & Co.Lower TargetOverweight$128.00 ➝ $115.00
4/9/2020Raymond JamesLower TargetOutperform$122.00 ➝ $110.00
3/30/2020SunTrust BanksReiterated RatingBuy$130.00
3/30/2020BTIG ResearchLower TargetHold ➝ Buy$124.00 ➝ $102.00
3/30/2020Needham & Company LLCDowngradeStrong-Buy ➝ Buy$134.00 ➝ $109.00
3/27/2020Morgan StanleyLower TargetEqual Weight$123.00 ➝ $112.00
3/27/2020CitigroupLower TargetBuy$124.00 ➝ $105.00
3/25/2020DZ BankUpgradeHold ➝ Buy$90.00
3/6/2020Credit Suisse GroupLower TargetOutperform$126.00 ➝ $121.00
3/4/2020CitigroupInitiated CoverageBuy$124.00
2/19/2020Raymond JamesBoost TargetOutperform$121.00 ➝ $122.00
2/19/2020BTIG ResearchLower TargetBuy$126.00 ➝ $124.00
2/18/2020Piper SandlerReiterated RatingBuy$135.00
2/18/2020CfraBoost TargetBuy$126.00 ➝ $127.00
2/17/2020Credit Suisse GroupReiterated RatingBuy$126.00
2/12/2020The Goldman Sachs GroupInitiated CoverageSell$118.00
1/22/2020Piper SandlerBoost TargetOverweight$125.00 ➝ $135.00
1/16/2020UBS GroupBoost TargetBuy$127.00 ➝ $130.00
1/7/2020SunTrust BanksInitiated CoverageBuy$130.00
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$99.00
1/2/2020CitigroupDowngradeBuy ➝ Neutral
1/2/2020GuggenheimUpgradeNeutral ➝ Buy$135.00
12/20/2019JPMorgan Chase & Co.Boost TargetOverweight$122.00 ➝ $128.00
12/17/2019Morgan StanleyBoost TargetEqual Weight$116.00 ➝ $123.00
11/25/2019ArgusBoost TargetBuy$135.00
(Data available from 11/21/2019 forward)

News Sentiment Rating

1.00 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 38 very positive mentions
  • 26 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
4/24/2024
  • 49 very positive mentions
  • 48 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
5/24/2024
  • 54 very positive mentions
  • 30 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
6/23/2024
  • 34 very positive mentions
  • 15 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
7/23/2024
  • 39 very positive mentions
  • 44 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
8/22/2024
  • 52 very positive mentions
  • 29 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/21/2024
  • 36 very positive mentions
  • 28 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
Mentions as of
10/21/2024
  • 76 very positive mentions
  • 53 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
11/20/2024

Current Sentiment

  • 76 very positive mentions
  • 53 positive mentions
  • 4 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Medtronic logo
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $84.11
Low: $83.55
High: $84.98

50 Day Range

MA: $89.17
Low: $84.11
High: $92.27

52 Week Range

Now: $84.11
Low: $75.96
High: $92.68

Volume

7,278,674 shs

Average Volume

6,274,537 shs

Market Capitalization

$107.87 billion

P/E Ratio

28.42

Dividend Yield

3.20%

Beta

0.84

Frequently Asked Questions

What sell-side analysts currently cover shares of Medtronic?

The following sell-side analysts have issued research reports on Medtronic in the last year: Barclays PLC, Citigroup Inc., Daiwa America, Evercore ISI, JPMorgan Chase & Co., Mizuho, Morgan Stanley, Needham & Company LLC, Oppenheimer Holdings Inc., Piper Sandler, Robert W. Baird, Royal Bank of Canada, Sanford C. Bernstein, Stifel Nicolaus, The Goldman Sachs Group, Inc., Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for MDT.

What is the current price target for Medtronic?

0 Wall Street analysts have set twelve-month price targets for Medtronic in the last year. Their average twelve-month price target is $95.19, suggesting a possible upside of 13.2%. Barclays PLC has the highest price target set, predicting MDT will reach $105.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $83.00 for Medtronic in the next year.
View the latest price targets for MDT.

What is the current consensus analyst rating for Medtronic?

Medtronic currently has 1 sell rating, 9 hold ratings, 7 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in MDT, but not buy more shares or sell existing shares.
View the latest ratings for MDT.

What other companies compete with Medtronic?

Other companies that are similar to Medtronic include Abbott Laboratories, Intuitive Surgical, Stryker, Boston Scientific and Becton, Dickinson and Company. Learn More about companies similar to Medtronic.

How do I contact Medtronic's investor relations team?

Medtronic's physical mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company's listed phone number is (531) 438-1700 and its investor relations email address is [email protected]. The official website for Medtronic is www.medtronic.com. Learn More about contacing Medtronic investor relations.